Total Payments
$7,497
2024 Payments
$3,258
Companies
24
Transactions
365
Medicare Patients
220
Medicare Billing
$18,650
Payment Breakdown by Category
Food & Beverage$7,251 (96.7%)
Education$245.80 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,251 | 362 | 96.7% |
| Education | $245.80 | 3 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,373 | 72 | $0 (2024) |
| Janssen Biotech, Inc. | $866.15 | 39 | $0 (2024) |
| Incyte Corporation | $753.73 | 38 | $0 (2024) |
| GENZYME CORPORATION | $750.07 | 22 | $0 (2024) |
| PFIZER INC. | $655.69 | 38 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $505.28 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $387.20 | 17 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $382.99 | 24 | $0 (2024) |
| Lilly USA, LLC | $329.48 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $299.41 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,258 | 161 | Incyte Corporation ($510.49) |
| 2023 | $2,101 | 100 | Janssen Biotech, Inc. ($366.37) |
| 2022 | $1,255 | 56 | ABBVIE INC. ($468.55) |
| 2021 | $883.08 | 48 | AbbVie Inc. ($219.52) |
All Payment Transactions
365 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.36 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.47 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $38.72 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND, EBGLYSS | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.36 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $1.54 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.65 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Inflammation | ||||||
| 11/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.31 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 220 | 366 | $46,725 | $18,650 |
Total Patients
220
Total Services
366
Medicare Billing
$18,650
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 112 | $15,120 | $6,785 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 54 | $10,800 | $4,589 | 42.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 26 | 35 | $6,125 | $2,600 | 42.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $3,705 | $1,472 | 39.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 19 | 23 | $4,140 | $1,460 | 35.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 26 | 37 | $4,255 | $1,359 | 31.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 18 | 86 | $2,580 | $385.65 | 14.9% |
About Dana Vered
Dana Vered is a Licensed Practical Nurse healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2019. The National Provider Identifier (NPI) number assigned to this provider is 1568935468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dana Vered has received a total of $7,497 in payments from pharmaceutical and medical device companies, with $3,258 received in 2024. These payments were reported across 365 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($7,251).
As a Medicare-enrolled provider, Vered has provided services to 220 Medicare beneficiaries, totaling 366 services with total Medicare billing of $18,650. Data is available for 1 year (2023–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Licensed Practical Nurse
- Location Southfield, MI
- Active Since 01/03/2019
- Last Updated 01/04/2019
- Taxonomy Code 164W00000X
- Entity Type Individual
- NPI Number 1568935468
Products in Payments
- DUPIXENT (Biological) $1,237
- OPZELURA (Drug) $753.73
- TREMFYA (Drug) $702.28
- RINVOQ (Biological) $697.75
- SKYRIZI (Biological) $523.90
- EUCRISA (Drug) $516.63
- Sotyktu (Drug) $348.00
- COSENTYX (Drug) $281.28
- TALTZ (Drug) $277.16
- Ilumya (Biological) $188.18
- Otezla (Drug) $183.23
- REMICADE (Biological) $163.87
- ADBRY (Biological) $154.91
- CIBINQO (Drug) $139.06
- VTAMA (Drug) $134.04
- HUMIRA (Biological) $133.21
- ILUMYA (Biological) $97.76
- Winlevi (Drug) $97.05
- Zoryve (Drug) $78.86
- ENSTILAR (Drug) $75.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Licensed Practical Nurse Doctors in Southfield
Mrs. Sheba Brooks, Lpn, LPN
Licensed Practical Nurse
Licensed Practical Nurse
Mrs. Carmela Richardson, Llmsw,Lpn, LLMSW,LPN
Licensed Practical Nurse
Licensed Practical Nurse
Ms. Ann Foster, Licensed Practical N, LICENSED PRACTICAL N
Licensed Practical Nurse
Licensed Practical Nurse
Sheila Pugh, L.p.n, L.P.N
Licensed Practical Nurse
Licensed Practical Nurse
Vena Jenkins, Practical Nurse, PRACTICAL NURSE
Licensed Practical Nurse
Licensed Practical Nurse
Ms. Tracey Boyd
Licensed Practical Nurse
Licensed Practical Nurse